Abstracts Archive - Page 849 of 2425 - ACR Meeting Abstracts

Abstract Number: 1359 • 2019 ACR/ARP Annual Meeting
Correlation of Ultrasound Guided Synovial Biopsies and Surgical Synovial Biopsies in Patients with Inflammatory Arthritis
Khin Lim¹, Ami Ben-artzi ¹, Lindsy Forbess ¹, Shimon Faber ² and Mariko Ishimori ¹, ¹Cedars-Sinai Medical Center, Los Angeles, CA, ²Cedars Sinai Medical Center, Los Angeles, CA
Background/Purpose: Synovial biopsy is often performed when other methods of evaluation prove non-diagnostic in the assessment of persistent joint synovitis, whether in the setting of…
Abstract Number: 1360 • 2019 ACR/ARP Annual Meeting
Ultrasound Guided Synovial Biopsies Safely Aid in the Assessment of Inflammatory Arthritis
Khin Lim¹, Ami Ben-artzi ¹, Lindsy Forbess ¹, Swamy Venuturupalli ², John Jalas ³ and Mariko Ishimori ¹, ¹Cedars-Sinai Medical Center, Los Angeles, CA, ²Cedars Sinai Medical Center, Los Angeles, CA, ³Saint John Health Center, Los Angeles, CA
Background/Purpose: Synovial biopsies have an important role in the diagnostic evaluation of patients with undifferentiated inflammatory arthritis (UIA) whose clinical examination and blood and synovial…
Abstract Number: 1361 • 2019 ACR/ARP Annual Meeting
Utility of Rheumatoid Arthritis Impact of Disease (RAID) in Routine Care; Identification of Patients Achieving DAS28 Remission or Low Disease Activity, and Burden of Unmet Patient Reported Outcomes
Jatin Mistry ¹, Margaret Sibley ², Catherine Smith ³, Malama Sumbwanyambe ² and Patrick Kiely², ¹St George's University of London, London, United Kingdom, ²St George's University Hospitals NHS Trust, London, United Kingdom, ³St Georges University Hospitals NHS Foundation Trust, London, United Kingdom
Background/Purpose: ACR/EULAR guidelines recommend remission or low DAS28 as the treat to target goal for patients with rheumatoid arthritis (RA). Alternative patient reported outcomes include…
Abstract Number: 1362 • 2019 ACR/ARP Annual Meeting
Relationship Between Waking Functions and Disease Activity in Rheumatoid Arthritis Patients Analyzed by Wearable Device
Masahiro Tada¹, Yutaro Yamada ², Koji Mandai ² and Noriaki Hidaka ¹, ¹Osaka City General Hospital, Osaka, Japan, ²Osaka City University Graduate School of Medicine, Osaka, Japan
Background/Purpose: We reported that the prevalence of sarcopenia was 28% and locomotive syndrome was 52% in patients with rheumatoid arthritis (RA)1. It is unknown that…
Abstract Number: 1363 • 2019 ACR/ARP Annual Meeting
Longitudinal Work Transitions in Early Inflammatory Arthritis Patients: Are There Targets for Intervention to Improve Employment?
Lily SH Lim¹, Doris Cheung ¹, Kaviul Mohamed ², Diane Lacaille ³, Eleanor M. Pullenayegum ⁴ and Carol Hitchon ¹, ¹University of Manitoba, Winnipeg, MB, Canada, ²University of Toronto, Toronto, ON, Canada, ³Arthritis Research Canada and University of British Columbia, Vancouver, BC, Canada, ⁴Child Health Evaluative Sciences, The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
Background/Purpose: Historically, increasing proportions of patients with rheumatoid arthritis stop working on long-term follow-up, often due to arthritis. The trajectory of work transitions in early…
Abstract Number: 1364 • 2019 ACR/ARP Annual Meeting
Affect of Obesity on Multi-Biomarker Disease Activity (MBDA) Measurements in Rheumatoid Arthritis (RA) Patients
Yael Ross¹, Madhavi Siddhanthi ², Lewis VanBrackle ³, David Carpenter ⁴, Aishwarya Rallabhandy ⁵ and Mohammad Kamran ², ¹WellStar Kennestone regional medical center, Atlanta, GA, ²WellStar Medical Group, Marietta, GA, ³Kennesaw State University, Kennesaw, ⁴WellStar Kennestone regional medical center, Marietta, ⁵High School, Marietta
Background/Purpose: The goal for treatment of RA is to obtain low disease activity for better outcomes. In order to achieve low disease activity, it is…
Abstract Number: 1365 • 2019 ACR/ARP Annual Meeting
Construct Validation of PROMIS Short Form and Profile-29 T-Scores with SF-36 in Rheumatoid Arthritis Patients Treated for 1 Year: Results from a Real World Evidence-Based Study in the United States
Clifton Bingham¹, Shelly Kafka ², Shawn Black ³, Stephen Xu ⁴ and Jeffrey Curtis ⁵, ¹Johns Hopkins University, Baltimore, MD, ²Janssen Scientific Affairs, LLC, Horsham, PA, ³Janssen Scientific Affairs, LLC, Horsham, RI, ⁴Janssen Research & Development, LLC, Spring House, PA, ⁵University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Use of PROs to assess health-related quality of life in clinical practice, research studies, and clinical trials in Rheumatoid Arthritis (RA) remains an ongoing…
Abstract Number: 1366 • 2019 ACR/ARP Annual Meeting
Self-joint Counts by People with Rheumatoid Arthritis: Does a Video Increase Accuracy and Does It Matter?
Rebecca Grainger¹, Simon Stebbings ², William Taylor ¹, Andrew Harrison ¹, Celina Capistrano ¹, Niamh Fanning ³ and Lisa Stamp ⁴, ¹University of Otago, Wellington, New Zealand, ²University of Otago, Dunedin, New Zealand, ³University of Otago, Christchurch, Christchurch, New Zealand, ⁴University of Otago, Christchurch, New Zealand
Background/Purpose: As a tool for self-monitoring and reporting RA disease activity, a smartphone app was developed to enable people with rheumatoid arthritis (RA) to record…
Abstract Number: 1367 • 2019 ACR/ARP Annual Meeting
An Engineered Glove for the Computerised Quantification of Hand Disability in Rheumatoid Arthritis
Massimo Patane' ¹, Luca Carmisciano ², Emanuele Gotelli ³, Veronica Tomatis ⁴, Francesco Cattelan ⁵, Elisa Alessandri ⁶, Alessio Signori ², Massimo Ghio ⁷, Vanessa Smith ⁸ and Maurizio Cutolo⁹, ¹Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, Genoa, Italy, ²Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italy, ³Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Genoa, Italy, ⁴Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Genoa, Italy, ⁵Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy, ⁶Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, Genova, ⁷Research Laboratory and Academic Division of the Clinical Rheumatology Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, Genoa, Italy, ⁸Department of Rheumatology, Ghent University Hospital; Department of Internal Medicine, Ghent University; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium, ⁹Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genoa, Italy
Background/Purpose: Background Rheumatoid arthritis (RA) is a long-term, progressive, and disabling autoimmune disease. The disease activity can be quantified by the Disease Activity Score 28-joint count…
Abstract Number: 1368 • 2019 ACR/ARP Annual Meeting
One Size Fits All : Replacing ESR by γGT in DAS28 Calculation Permits a Dual Evaluation of Joint Activity Together with Cardiovascular Risk
Hélène Vergneault ¹, Eloïse Vandebeuque ², Veronica Codullo ¹, Yannick Allanore ³ and Jérôme Avouac¹, ¹Cochin Hospital, Paris, France, ²Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, ³Dept. of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France, Paris, France
Background/Purpose: Patients with rheumatoid arthritis (RA) experience premature mortality that is largely due to cardiovascular disease (CVD). Ample evidence suggests that elevated γGT activity is…
Abstract Number: 1369 • 2019 ACR/ARP Annual Meeting
Angiogenic Factors for Assessing Rheumatoid Arthritis in the Era of Sonographic Diagnosis and Biologic Therapy
Ji-Won Kim¹, Jin-Sun Kong ², Youngjae Park ³ and Wan-Uk Kim ³, ¹Catholic University of Daegu School of Medicine, Daegu, Republic of Korea, ²Catholic University of Korea, College of Medicine, Seoul, Republic of Korea, ³Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Background/Purpose: Previously, we demonstrated the direct pro-inflammatory role of the vascular endothelial growth factor (VEGF) and the placenta growth factor (PlGF), and angiogenic factors in…
Abstract Number: 1370 • 2019 ACR/ARP Annual Meeting
Not All Joints Are Equal: Challenge DAS28 System and Identify Factors Leading to a Mismatch Between T2T and HAQ Among RA Patients Through Data Mining from Smart System of Disease Management (SSDM)
Jing Yang¹, Zhenbiao Wu ², Yongfu Wang ³, Hua Wei ⁴, Yu Zhang ¹, Xiaoling Liu ⁵, Xiaofeng Rong ⁶, Jinmei Zou ¹, Xiaofei Shi ⁷, Hongbin Li ⁸, Rui Wu ⁹, Xiaoli Deng ¹⁰, Huiqiong Zhou ¹¹, Yuan Jia ¹², Wei Zhao ¹³, Shi Chen ¹², Xuewu Zhang ¹², Yingnan Li ¹⁴, Yingkun Nie ¹⁴, Yifang Mei ¹⁵, Jianyu Zhang ¹⁶, Hanyou Mo ¹⁷, li Sun ¹⁸, Yanfei Chen ¹⁹, Haili Shen ²⁰, Dongsheng Li ²¹, Yonggang Zhao ²², Hui Xiao ²³, Bing Wu ²⁴, Yuhua Jia ²² and Fei Xiao ²⁵, ¹Central Hospital of MianYang, Mianyang, Sichuan, China (People's Republic), ²The First Affiliated Hospital of The Fourth Military Medical University, Xian, Shanxi, China (People's Republic), ³The First Affiliated Hospital of BaoTou Medical College, Baotou, Nei Mongol, China (People's Republic), ⁴Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), ⁵The 1st Affiliated Hospital of Guangzhou University of TCM, Guangzhou, China (People's Republic), ⁶The 1st Affiliated hospital of Chongqing medical University, Chongqing, Chongqing, China (People's Republic), ⁷First Affiliated Hospital of Henan University of Science and Technology, luoyang, Henan, China (People's Republic), ⁸The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Nei Mongol, China (People's Republic), ⁹The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (People's Republic), ¹⁰Peking University Third Hospital, Beijing, Beijing, China (People's Republic), ¹¹Fourth Medical Center of PLA Genal Hospital, Beijing, Beijing, China (People's Republic), ¹²Peking University People's Hospital, Beijing, Beijing, China (People's Republic), ¹³Chinese PLA General Hospital, Beijing, Beijing, China (People's Republic), ¹⁴The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China (People's Republic), ¹⁵The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China (People's Republic), ¹⁶The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China (People's Republic), ¹⁷Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China (People's Republic), ¹⁸The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (People's Republic), ¹⁹The First Hospital of Lanzhou University, Lanzhou, Gansu, China (People's Republic), ²⁰The Second Hospital of Lanzhou University, Lanzhou, Gansu, China (People's Republic), ²¹Ganzhou People's Hospital, Ganzhou, Jiangxi, China (People's Republic), ²²Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), ²³Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), ²⁴Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), ²⁵Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)
Background/Purpose: Treat to target (T2T), achieving a DAS28 score lower than 3.2, is the strategy recommended by ACR and EULAR. Health assessment questionnaire (HAQ) is…
Abstract Number: 1371 • 2019 ACR/ARP Annual Meeting
Create an Algorithm of Outcome Forecasting and Decision Making for RA Treatment: Data Mining and Machine Learning via the Smart System of Disease Management (SSDM)
Rong Mu¹, Chun Li ², Jing Yang ³, Xiaohan Wang ⁴, Bin Wu ⁵, Fengxiao Zhang ⁶, Yong Wang ⁷, Li Qin ⁸, Cundong Mi ⁹, Huifang Guo ¹⁰, Wei Wei ¹¹, Wei Liu ¹², Qingchun Huang ¹³, Jing Lu ¹⁴, Yang Liu ¹⁵, Huiling Li ¹⁶, Bing Wu ¹⁷, Hui Xiao ¹⁸, Yuhua Jia ¹⁹ and Fei Xiao ²⁰, ¹People's Hospital, Beijing University Medical School, Beijing, China (People's Republic), ²People's Hospital, Beijing University Medical School, Beijing, Beijing, China (People's Republic), ³Central Hospital of MianYang, Mianyang, Sichuan, China (People's Republic), ⁴Anyang district hospital, Fuyang, Hainan, China (People's Republic), ⁵Chongqing Hospital of Traditional Chinese Medicine, Chongqing, Chongqing, China (People's Republic), ⁶Hebei General Hospital, Shijiazhuang, Hebei, China (People's Republic), ⁷The first Hospital Affiliated to AMU (Southernwest Hospital), Chongqing, China (People's Republic), ⁸The No.3 People’s Hospital of HuZhou City, Huzhou, Zhejiang, China (People's Republic), ⁹The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (People's Republic), ¹⁰The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (People's Republic), ¹¹Tianjin Medical University General Hospital, Tianjin, Tianjin, China (People's Republic), ¹²First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (People's Republic), ¹³The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China (People's Republic), ¹⁴First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China (People's Republic), ¹⁵Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, Nei Mongol, China (People's Republic), ¹⁶Hubei Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China (People's Republic), ¹⁷Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), ¹⁸Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), ¹⁹Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), ²⁰Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)
Background/Purpose: Daily health care deals with a wide spectrum of RA patients from statuses of remission (R) to disease activities at low (L), moderate (M)…
Abstract Number: 1372 • 2019 ACR/ARP Annual Meeting
Adherence to Treatment with Intravenous Biological Agents in Patients with Rheumatoid Arthritis
Gisele Alejandra Luna¹, fernando dal Pra ², Emilce Schneeberger ³, Leonela Lysseth Macias Oviedo ⁴ and Gustavo Citera ⁵, ¹Instituto de Rehabilitación Psicofísica, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, ²Instituto Rehabilitacion Psicofisica, CABA, Ciudad Autonoma de Buenos Aires, Argentina, ³Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁴Instituto de Rehabilitacion Psicofisica, CABA, Ciudad Autonoma de Buenos Aires, Argentina, ⁵Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Background/Purpose: The adherence to the therapeutic regimen in patients with Rheumatoid Arthritis (RA) varies between 30 and 80%. Classically, it is mentioned that the adherence…
Abstract Number: 1373 • 2019 ACR/ARP Annual Meeting
Performance of CQR5 vs CQR19 in the Evaluation of Adherence to Tofacitinib in Daily Clinical Practice
Tatiana Barbich¹, Osvaldo Luis Cerda ², Emilce Schneeberger ³ and Gustavo Citera ⁴, ¹Instituto de Rehabilitación Psicofísica, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, ²Instituto de Rehabilitacion Psicofisica, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, ³Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁴Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Background/Purpose: To evaluate the adherence to treatment with Tofacitinib in patients with Rheumatoid Arthritis (RA) using both versions of the self-questionnaire Compliance Questionnaire Rheumatology: CQR19…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].